世界の吸入麻酔薬市場インサイト・予測(~2027)

QYResearchが発行した調査報告書(QY21AUG3568)
◆英語タイトル:Global Inhalation Anesthetic Drugs Market Insights and Forecast to 2027
◆商品コード:QY21AUG3568
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年8月(※2024年版があります。お問い合わせください。)
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは吸入麻酔薬の世界市場の現状について調査・分析し、2027年までの市場を予測しました。吸入麻酔薬の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(全身麻酔薬、局所麻酔薬)、用途別市場規模(美容整形、歯科、一般外科、形成外科)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・吸入麻酔薬の世界市場概要
・メーカー別の競争状況、市場シェア
・吸入麻酔薬の種類別市場規模:全身麻酔薬、局所麻酔薬
・吸入麻酔薬の用途別市場規模:美容整形、歯科、一般外科、形成外科
・北米の吸入麻酔薬市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの吸入麻酔薬市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの吸入麻酔薬市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の吸入麻酔薬市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの吸入麻酔薬市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan
・吸入麻酔薬のバリューチェーン・販売チャネル分析
・吸入麻酔薬の世界市場動向
【レポートの概要】

Market Analysis and Insights: Global Inhalation Anesthetic Drugs Market
The global Inhalation Anesthetic Drugs market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Inhalation Anesthetic Drugs Scope and Segment
Inhalation Anesthetic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inhalation Anesthetic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
General Anesthesia Drugs
Local Anesthesia Drugs

Segment by Application
Cosmetic Surgery
Dental Surgery
General Surgey
Plastic Surgery

By Company
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

【レポートの目次】

1 Study Coverage
1.1 Inhalation Anesthetic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Inhalation Anesthetic Drugs Market Size Growth Rate by Type
1.2.2 General Anesthesia Drugs
1.2.3 Local Anesthesia Drugs
1.3 Market by Application
1.3.1 Global Inhalation Anesthetic Drugs Market Size Growth Rate by Application
1.3.2 Cosmetic Surgery
1.3.3 Dental Surgery
1.3.4 General Surgey
1.3.5 Plastic Surgery
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Inhalation Anesthetic Drugs Sales Estimates and Forecasts 2016-2027
2.2 Global Inhalation Anesthetic Drugs Revenue Estimates and Forecasts 2016-2027
2.3 Global Inhalation Anesthetic Drugs Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Inhalation Anesthetic Drugs Regions by Sales
2.4.1 Global Top Inhalation Anesthetic Drugs Regions by Sales (2016-2021)
2.4.2 Global Top Inhalation Anesthetic Drugs Regions by Sales (2022-2027)
2.5 Global Top Inhalation Anesthetic Drugs Regions by Revenue
2.5.1 Global Top Inhalation Anesthetic Drugs Regions by Revenue (2016-2021)
2.5.2 Global Top Inhalation Anesthetic Drugs Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Inhalation Anesthetic Drugs Sales by Manufacturers
3.1.1 Global Top Inhalation Anesthetic Drugs Manufacturers by Sales (2016-2021)
3.1.2 Global Top Inhalation Anesthetic Drugs Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Inhalation Anesthetic Drugs Sales in 2020
3.2 Global Inhalation Anesthetic Drugs Revenue by Manufacturers
3.2.1 Global Top Inhalation Anesthetic Drugs Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Inhalation Anesthetic Drugs Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Inhalation Anesthetic Drugs Revenue in 2020
3.3 Global Inhalation Anesthetic Drugs Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Inhalation Anesthetic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Inhalation Anesthetic Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Inhalation Anesthetic Drugs Sales by Type
4.1.1 Global Inhalation Anesthetic Drugs Historical Sales by Type (2016-2021)
4.1.2 Global Inhalation Anesthetic Drugs Forecasted Sales by Type (2022-2027)
4.1.3 Global Inhalation Anesthetic Drugs Sales Market Share by Type (2016-2027)
4.2 Global Inhalation Anesthetic Drugs Revenue by Type
4.2.1 Global Inhalation Anesthetic Drugs Historical Revenue by Type (2016-2021)
4.2.2 Global Inhalation Anesthetic Drugs Forecasted Revenue by Type (2022-2027)
4.2.3 Global Inhalation Anesthetic Drugs Revenue Market Share by Type (2016-2027)
4.3 Global Inhalation Anesthetic Drugs Price by Type
4.3.1 Global Inhalation Anesthetic Drugs Price by Type (2016-2021)
4.3.2 Global Inhalation Anesthetic Drugs Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Inhalation Anesthetic Drugs Sales by Application
5.1.1 Global Inhalation Anesthetic Drugs Historical Sales by Application (2016-2021)
5.1.2 Global Inhalation Anesthetic Drugs Forecasted Sales by Application (2022-2027)
5.1.3 Global Inhalation Anesthetic Drugs Sales Market Share by Application (2016-2027)
5.2 Global Inhalation Anesthetic Drugs Revenue by Application
5.2.1 Global Inhalation Anesthetic Drugs Historical Revenue by Application (2016-2021)
5.2.2 Global Inhalation Anesthetic Drugs Forecasted Revenue by Application (2022-2027)
5.2.3 Global Inhalation Anesthetic Drugs Revenue Market Share by Application (2016-2027)
5.3 Global Inhalation Anesthetic Drugs Price by Application
5.3.1 Global Inhalation Anesthetic Drugs Price by Application (2016-2021)
5.3.2 Global Inhalation Anesthetic Drugs Price Forecast by Application (2022-2027)

6 North America
6.1 North America Inhalation Anesthetic Drugs Market Size by Type
6.1.1 North America Inhalation Anesthetic Drugs Sales by Type (2016-2027)
6.1.2 North America Inhalation Anesthetic Drugs Revenue by Type (2016-2027)
6.2 North America Inhalation Anesthetic Drugs Market Size by Application
6.2.1 North America Inhalation Anesthetic Drugs Sales by Application (2016-2027)
6.2.2 North America Inhalation Anesthetic Drugs Revenue by Application (2016-2027)
6.3 North America Inhalation Anesthetic Drugs Market Size by Country
6.3.1 North America Inhalation Anesthetic Drugs Sales by Country (2016-2027)
6.3.2 North America Inhalation Anesthetic Drugs Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Inhalation Anesthetic Drugs Market Size by Type
7.1.1 Europe Inhalation Anesthetic Drugs Sales by Type (2016-2027)
7.1.2 Europe Inhalation Anesthetic Drugs Revenue by Type (2016-2027)
7.2 Europe Inhalation Anesthetic Drugs Market Size by Application
7.2.1 Europe Inhalation Anesthetic Drugs Sales by Application (2016-2027)
7.2.2 Europe Inhalation Anesthetic Drugs Revenue by Application (2016-2027)
7.3 Europe Inhalation Anesthetic Drugs Market Size by Country
7.3.1 Europe Inhalation Anesthetic Drugs Sales by Country (2016-2027)
7.3.2 Europe Inhalation Anesthetic Drugs Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Inhalation Anesthetic Drugs Market Size by Type
8.1.1 Asia Pacific Inhalation Anesthetic Drugs Sales by Type (2016-2027)
8.1.2 Asia Pacific Inhalation Anesthetic Drugs Revenue by Type (2016-2027)
8.2 Asia Pacific Inhalation Anesthetic Drugs Market Size by Application
8.2.1 Asia Pacific Inhalation Anesthetic Drugs Sales by Application (2016-2027)
8.2.2 Asia Pacific Inhalation Anesthetic Drugs Revenue by Application (2016-2027)
8.3 Asia Pacific Inhalation Anesthetic Drugs Market Size by Region
8.3.1 Asia Pacific Inhalation Anesthetic Drugs Sales by Region (2016-2027)
8.3.2 Asia Pacific Inhalation Anesthetic Drugs Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Inhalation Anesthetic Drugs Market Size by Type
9.1.1 Latin America Inhalation Anesthetic Drugs Sales by Type (2016-2027)
9.1.2 Latin America Inhalation Anesthetic Drugs Revenue by Type (2016-2027)
9.2 Latin America Inhalation Anesthetic Drugs Market Size by Application
9.2.1 Latin America Inhalation Anesthetic Drugs Sales by Application (2016-2027)
9.2.2 Latin America Inhalation Anesthetic Drugs Revenue by Application (2016-2027)
9.3 Latin America Inhalation Anesthetic Drugs Market Size by Country
9.3.1 Latin America Inhalation Anesthetic Drugs Sales by Country (2016-2027)
9.3.2 Latin America Inhalation Anesthetic Drugs Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Inhalation Anesthetic Drugs Market Size by Type
10.1.1 Middle East and Africa Inhalation Anesthetic Drugs Sales by Type (2016-2027)
10.1.2 Middle East and Africa Inhalation Anesthetic Drugs Revenue by Type (2016-2027)
10.2 Middle East and Africa Inhalation Anesthetic Drugs Market Size by Application
10.2.1 Middle East and Africa Inhalation Anesthetic Drugs Sales by Application (2016-2027)
10.2.2 Middle East and Africa Inhalation Anesthetic Drugs Revenue by Application (2016-2027)
10.3 Middle East and Africa Inhalation Anesthetic Drugs Market Size by Country
10.3.1 Middle East and Africa Inhalation Anesthetic Drugs Sales by Country (2016-2027)
10.3.2 Middle East and Africa Inhalation Anesthetic Drugs Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Corporation Information
11.1.2 Astrazeneca Overview
11.1.3 Astrazeneca Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Astrazeneca Inhalation Anesthetic Drugs Product Description
11.1.5 Astrazeneca Recent Developments
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Corporation Information
11.2.2 Fresenius-Kabi Overview
11.2.3 Fresenius-Kabi Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Fresenius-Kabi Inhalation Anesthetic Drugs Product Description
11.2.5 Fresenius-Kabi Recent Developments
11.3 AbbVie
11.3.1 AbbVie Corporation Information
11.3.2 AbbVie Overview
11.3.3 AbbVie Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 AbbVie Inhalation Anesthetic Drugs Product Description
11.3.5 AbbVie Recent Developments
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Corporation Information
11.4.2 Baxter Healthcare Overview
11.4.3 Baxter Healthcare Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Baxter Healthcare Inhalation Anesthetic Drugs Product Description
11.4.5 Baxter Healthcare Recent Developments
11.5 B.Braun
11.5.1 B.Braun Corporation Information
11.5.2 B.Braun Overview
11.5.3 B.Braun Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 B.Braun Inhalation Anesthetic Drugs Product Description
11.5.5 B.Braun Recent Developments
11.6 Maruishi
11.6.1 Maruishi Corporation Information
11.6.2 Maruishi Overview
11.6.3 Maruishi Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Maruishi Inhalation Anesthetic Drugs Product Description
11.6.5 Maruishi Recent Developments
11.7 Piramal
11.7.1 Piramal Corporation Information
11.7.2 Piramal Overview
11.7.3 Piramal Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Piramal Inhalation Anesthetic Drugs Product Description
11.7.5 Piramal Recent Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Corporation Information
11.8.2 Hikma Pharmaceuticals Overview
11.8.3 Hikma Pharmaceuticals Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Hikma Pharmaceuticals Inhalation Anesthetic Drugs Product Description
11.8.5 Hikma Pharmaceuticals Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Overview
11.9.3 Mylan Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Mylan Inhalation Anesthetic Drugs Product Description
11.9.5 Mylan Recent Developments
11.10 Nhwa
11.10.1 Nhwa Corporation Information
11.10.2 Nhwa Overview
11.10.3 Nhwa Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Nhwa Inhalation Anesthetic Drugs Product Description
11.10.5 Nhwa Recent Developments
11.11 Hengrui
11.11.1 Hengrui Corporation Information
11.11.2 Hengrui Overview
11.11.3 Hengrui Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Hengrui Inhalation Anesthetic Drugs Product Description
11.11.5 Hengrui Recent Developments
11.12 Lunan
11.12.1 Lunan Corporation Information
11.12.2 Lunan Overview
11.12.3 Lunan Inhalation Anesthetic Drugs Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Lunan Inhalation Anesthetic Drugs Product Description
11.12.5 Lunan Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Inhalation Anesthetic Drugs Value Chain Analysis
12.2 Inhalation Anesthetic Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inhalation Anesthetic Drugs Production Mode & Process
12.4 Inhalation Anesthetic Drugs Sales and Marketing
12.4.1 Inhalation Anesthetic Drugs Sales Channels
12.4.2 Inhalation Anesthetic Drugs Distributors
12.5 Inhalation Anesthetic Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Inhalation Anesthetic Drugs Industry Trends
13.2 Inhalation Anesthetic Drugs Market Drivers
13.3 Inhalation Anesthetic Drugs Market Challenges
13.4 Inhalation Anesthetic Drugs Market Restraints

14 Key Findings in The Global Inhalation Anesthetic Drugs Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の吸入麻酔薬市場インサイト・予測(~2027)(Global Inhalation Anesthetic Drugs Market Insights and Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。